Reviewed,
UniProtKB/Swiss-Prot Q01344 (IL5RA_HUMAN)
Last modified
June 16, 2009.
Version 96.
History...
Clusters with 100%,
90%,
50% identity |
Documents (7) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Interleukin-5 receptor subunit alpha Short name=IL-5R-alpha Alternative name(s): CDw125 CD_antigen=CD125 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 420 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | This is the receptor for interleukin-5. The alpha chain binds to IL5. |
| Subunit structure | Heterodimer of an alpha and a beta subunit. The beta subunit is common to the IL3, IL5 and GM-CSF receptors. Interacts with SDCBP. |
| Subcellular location | |
| Tissue specificity | Expressed on eosinophils and basophils. |
| Domain | The WSXWS motif appears to be necessary for proper protein folding and thereby efficient intracellular transport and cell-surface receptor binding. The box 1 motif is required for JAK interaction and/or activation. |
| Sequence similarities | Belongs to the type I cytokine receptor family. Type 5 subfamily. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Membrane |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Domain | Signal Transmembrane |
| Molecular function | Receptor |
| PTM | Glycoprotein |
| Technical term | 3D-structure |
| Gene Ontology (GO) | |
| Biological process | cell proliferation Ref.2 Traceable author statement. Source: ProtInc signal transduction Ref.2Traceable author statement. Source: ProtInc |
| Cellular component | extracellular space Ref.3 Traceable author statement. Source: ProtInc integral to membrane Ref.3Traceable author statement. Source: ProtInc |
| Molecular function | interleukin-5 receptor activity Ref.3 Traceable author statement. Source: ProtInc |
| Complete GO annotation... | |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q01344-1) Also known as: Membrane-bound; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q01344-2) Also known as: Soluble-S1; The sequence of this isoform differs from the canonical sequence as follows: 333-335: NDE → FSR 336-420: Missing. | ||||||
| Isoform 3 (identifier: Q01344-3) Also known as: Soluble-S2; The sequence of this isoform differs from the canonical sequence as follows: 333-333: N → K 334-420: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 20 | 20 | |||||||
| Chain | 21 – 420 | 400 | Interleukin-5 receptor subunit alpha | PRO_0000010893 | |||||
Regions | |||||||||
| Topological domain | 21 – 342 | 322 | Extracellular Potential | ||||||
| Transmembrane | 343 – 362 | 20 | Potential | ||||||
| Topological domain | 363 – 420 | 58 | Cytoplasmic Potential | ||||||
| Motif | 322 – 326 | 5 | WSXWS motif | ||||||
| Motif | 371 – 379 | 9 | Box 1 motif | ||||||
Amino acid modifications | |||||||||
| Glycosylation | 35 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 131 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 216 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 244 | 1 | N-linked (GlcNAc...) Potential | ||||||
Natural variations | |||||||||
| Alternative sequence | 333 – 335 | 3 | NDE → FSR in isoform 2. | VSP_001678 | |||||
| Alternative sequence | 333 | 1 | N → K in isoform 3. | VSP_001680 | |||||
| Alternative sequence | 334 – 420 | 87 | Missing in isoform 3. | VSP_001681 | |||||
| Alternative sequence | 336 – 420 | 85 | Missing in isoform 2. | VSP_001679 | |||||
| Natural variant | 129 | 1 | I → V: dbSNP rs2290610. Ref.3 | VAR_020654 | |||||
| Natural variant | 262 | 1 | V → A: dbSNP rs17879690. Ref.3 | VAR_020655 | |||||
Experimental info | |||||||||
| Sequence conflict | 212 | 1 | A → S in AAA36110. Ref.1 | ||||||
| Sequence conflict | 212 | 1 | A → S in AAA59151. Ref.2 | ||||||
| Sequence conflict | 212 | 1 | A → S in AAA59152. Ref.2 | ||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| [1] | "A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF." Tavernier J., Devos R., Cornelis S., Tuypens T., van der Heyden J., Fiers W., Plaetinck G. Cell 66:1175-1184(1991) [PubMed: 1833065] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). |
| [2] | "Molecular cloning and expression of the human interleukin 5 receptor." Murata Y., Takaki S., Migita M., Kikuchi Y., Tominaga A., Takatsu K. J. Exp. Med. 175:341-351(1992) [PubMed: 1732409] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3), VARIANT VAL-129. Tissue: Peripheral blood. |
| [3] | "Molecular basis of the membrane-anchored and two soluble isoforms of the human interleukin 5 receptor alpha subunit." Tavernier J., Tuypens T., Plaetinck G., Verhee A., Fiers W., Devos R. Proc. Natl. Acad. Sci. U.S.A. 89:7041-7045(1992) [PubMed: 1495999] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3). |
| [4] | SeattleSNPs variation discovery resource Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS VAL-129 AND ALA-262. |
| [5] | "Molecular roots of degenerate specificity in syntenin's PDZ2 domain: reassessment of the PDZ recognition paradigm." Kang B.S., Cooper D.R., Devedjiev Y., Derewenda U., Derewenda Z.S. Structure 11:845-853(2003) [PubMed: 12842047] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.35 ANGSTROMS) OF 413-420 IN COMPLEX WITH SDCBP. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M75914 mRNA. Translation: AAA36110.1. X61176 mRNA. Translation: CAA43483.1. X62156 mRNA. Translation: CAA44081.1. M96651 mRNA. Translation: AAA59151.1. M96652 mRNA. Translation: AAA59152.1. AY642135 Genomic DNA. Translation: AAT45457.1. | |||||||||||||||||||
| IPI | IPI00221146. IPI00306687. IPI00395487. | ||||||||||||||||||
| PIR | A40267. | ||||||||||||||||||
| RefSeq | NP_000555.2. NP_783851.1. NP_783852.1. NP_783853.1. NP_783854.1. | ||||||||||||||||||
| UniGene | Hs.68876 | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| |||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| DIP | DIP:3510N. | ||||||||||||||||||
| IntAct | Q01344. 1 interaction. | ||||||||||||||||||
PTM databases | |||||||||||||||||||
| PhosphoSite | Q01344. | ||||||||||||||||||
Proteomic databases | |||||||||||||||||||
| PRIDE | Q01344. | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| Ensembl | ENSG00000091181. Homo sapiens. [Contig view] | ||||||||||||||||||
| GeneID | 3568. | ||||||||||||||||||
| KEGG | hsa:3568. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| GeneCards | GC03M003086. | ||||||||||||||||||
| H-InvDB | HIX0003005. | ||||||||||||||||||
| HGNC | HGNC:6017. IL5RA. | ||||||||||||||||||
| HPA | HPA013196. | ||||||||||||||||||
| MIM | 147851. gene. | ||||||||||||||||||
| PharmGKB | PA29834. | ||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| HOGENOM | Q01344. | ||||||||||||||||||
| HOVERGEN | Q01344. | ||||||||||||||||||
| OMA | Q01344. SLHCTWL. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| ArrayExpress | Q01344. | ||||||||||||||||||
| Bgee | Q01344. | ||||||||||||||||||
| CleanEx | HS_IL5RA. | ||||||||||||||||||
| GermOnline | ENSG00000091181. Homo sapiens. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| InterPro | IPR008957. Fibronectin_typ-III-like_fold. IPR003532. Short_hematopoietin_rcpt_2_CS. [Graphical view] | ||||||||||||||||||
| Gene3D | G3DSA:2.60.40.30. FN_III-like. 1 hit. | ||||||||||||||||||
| Pfam | PF10556. Haemat_rec_S_F2. 1 hit. [Graphical view] | ||||||||||||||||||
| PROSITE | PS01356. HEMATOPO_REC_S_F2. 1 hit. [Graphical view] | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Other Resources | |||||||||||||||||||
| NextBio | 13936. | ||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||
Entry information
| Entry name | IL5RA_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q01344 Secondary accession number(s): Q14633, Q15469, Q6ISX9 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
Relevant documents
| Human cell differentiation molecules CD nomenclature of surface proteins of human leucocytes and list of entries |
| Human chromosome 3 Human chromosome 3: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


